SARS-CoV-2感染患者中的急性肾损伤
该回顾性单中心研究纳入100例实验室确诊SARS-CoV-2感染并入住ICU的成人患者,按尿量和肌酐KDIGO标准定义AKI。81例(81%)发生AKI,其中1期44例、2期10例、3期27例。AKI严重程度与28天死亡率相关(P=0.013)。校正混杂因素后,改良SOFA评分每分和AKI均与结局相关;将C3、IL-6或铁蛋白强制纳入最终模型时,均与AKI无关联且未改变模型。结论:补体激活或炎症标志物与AKI无关联,但重症SARS-CoV-2感染中AKI比例高于既往报道且与结局相关。
要点
- ICU收治的SARS-CoV-2感染成人患者中,AKI发生率为81%(81/100),其中1期44例、2期10例、3期27例。
- AKI严重程度与28天死亡率相关(P=0.013)。
- 校正混杂因素后,改良SOFA评分每分和AKI均与结局相关。
- 将C3(每log OR 0.25;95%CI 0.01-4.66)、IL-6(每log OR 0.83;95%CI 0.51-1.34)或铁蛋白(每log OR 1.63;95%CI 0.84-3.32)强制纳入最终模型,均与AKI无关联且未改变模型。
- AKI发生前,AKI患者C3、IL-6和铁蛋白水平高于非AKI患者(未校正分析)。
适用人群与场景
- 实验室确诊SARS-CoV-2感染并入住大学医院ICU的成人患者。
诊断标准与关键阈值
- AKI定义:同时依据尿量和肌酐的KDIGO标准。
研究设计与关键结果
- 研究类型:回顾性单中心研究;样本量100例;人群:ICU收治的实验室确诊SARS-CoV-2感染成人患者。
- AKI发生81例(81%),其中1期44例、2期10例、3期27例。
- AKI严重程度与28天死亡率相关(P=0.013)。
- 未校正时,AKI患者C3、IL-6和铁蛋白水平高于非AKI患者。
- 校正混杂因素后,改良SOFA评分每分和AKI均与结局相关。
- 将C3(每log OR 0.25;95%CI 0.01-4.66)、IL-6(每log OR 0.83;95%CI 0.51-1.34)或铁蛋白(每log OR 1.63;95%CI 0.84-3.32)强制纳入最终模型,均与AKI无关联且未改变模型。
证据类型、等级与局限
- 证据类型:回顾性单中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在ICU收治的SARS-CoV-2感染成人患者中,AKI发生率高(81%)且与28天死亡率相关,提示应重视AKI的监测与分期。
- 补体激活或炎症标志物(C3、IL-6、铁蛋白)未显示与AKI独立相关,作者认为其不能作为AKI的独立预测指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Acute Kidney Injury (AKI) is a frequent complication of severe SARS-CoV-2 infection. Multiple mechanisms are involved in COVID-19-associated AKI, from direct viral infection and secondary inflammation to complement activation and microthrombosis. However, data are limited in critically-ill patients. In this study, we sought to describe the prevalence, risk factors and prognostic impact of AKI in this setting.
METHODS: Retrospective monocenter study including adult patients with laboratory confirmed SARS-CoV-2 infection admitted to the ICU of our university Hospital. AKI was defined according to both urinary output and creatinine KDIGO criteria.
RESULTS: Overall, 100 COVID-19 patients were admitted. AKI occurred in 81 patients (81%), including 44, 10 and 27 patients with AKI stage 1, 2 and 3 respectively. The severity of AKI was associated with mortality at day 28 (p = 0.013). Before adjustment, the third fraction of complement (C3), interleukin-6 (IL-6) and ferritin levels were higher in AKI patients. After adjustment for confounders, both severity (modified SOFA score per point) and AKI were associated with outcome. When forced in the final model, C3 (OR per log 0.25; 95% CI 0.01-4.66), IL-6 (OR per log 0.83; 95% CI 0.51-1.34), or ferritin (OR per log 1.63; 95% CI 0.84-3.32) were not associated with AKI and did not change the model.
CONCLUSION: In conclusion, we did not find any association between complement activation or inflammatory markers and AKI. Proportion of patients with AKI during severe SARS-CoV-2 infection is higher than previously reported and associated with outcome.
参考来源
- Joseph A, Zafrani L, Mabrouki A, et al. Acute kidney injury in patients with SARS-CoV-2 infection. Ann Intensive Care. 2020. PMID: 32880774. doi:10.1186/s13613-020-00734-z
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。